Kinesiotaping the Hand in Cerebral Palsy

February 25, 2014 updated by: hhotaman, Hacettepe University

Effects of Kinesiotaping the Hand of Children With Cerebral Palsy

BACKROUNDS: Thumb in palm deformity restricts hand function by prevent somatosensory input in the children with cerebral palsy who have spasticity in their hands.

OBJECTİVES: To investigate the effects of thenar palmar kinesiotape application with and without pressure on hand function in children with cerebral palsy. METHOD: 45 children were randomly allocated to one of the thenar taping groups either with or without pressure or to the control group. Nine hole peg test and nine parts puzzle test were used to measure hand function. The two study groups were evaluated initially, with taping 20 minutes later and 20 minutes after taping was removed.

Study Overview

Detailed Description

BACKROUNDS: Thumb in palm deformity restricts hand function by prevent somatosensory input in the children with cerebral palsy who have spasticity in their hands.

OBJECTİVES: To investigate the effects of thenar palmar kinesiotape application with and without pressure on upper extremity function in children with cerebral palsy. METHOD: 45 children were randomly allocated to one of the thenar taping groups either with or without pressure or to the control group. Nine hole peg test and nine parts puzzle test were used to measure upper extremity function. The two study groups were evaluated initially, with taping 20 minutes later and 20 minutes after taping was removed.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06100
        • Hacettepe University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of Cerebral Palsy
  • Stable clinical status
  • Hand and/ or wrist spasticity
  • No passive movement limitation
  • Receiving regular neurodevelopmental rehabilitation
  • Sufficient cognitive level

Exclusion criteria:

  • Surgery of the upper extremity
  • Orthotic treatment
  • Sensory deficit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: kinesiotape plus thenar pressure (PPTG)

In the kinesiotape plus thenar pressure (PPTG). Kinesiotape was applied which controled the cortical thumb sign. In addition a piece of plastazote aiming to give thenar pressure was also applied.

The amount of pressure was regulated so that the child felt the pressure without being irritated and without restriction in grasping functions.

In the kinesiotape plus thenar pressure (PPTG). Kinesiotape was applied to control the cortical thumb sign. In addition a piece of plastazote aiming to give thenar pressure was also applied.

The amount of pressure was regulated so that the child felt the pressure without being irritated and without restriction in grasping functions.

Experimental: Taping Group (TG)
In the taping group (TG) kinesiotape was applied to control the cortical thumb sign.
In the taping group (TG) kinesiotape was applied to control the cortical thumb sign.
No Intervention: Control Group (CG)
No application.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Nine hole peg test
Time Frame: at baseline (before application), at 20 minutes after application, at 20 minutes after application removed
at baseline (before application), at 20 minutes after application, at 20 minutes after application removed

Secondary Outcome Measures

Outcome Measure
Time Frame
nine parts puzzle test
Time Frame: at baseline (before application), at 20 minutes after application, at 20 minutes after application removed
at baseline (before application), at 20 minutes after application, at 20 minutes after application removed

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Fatma UYGUR, Prof. PhD., Hacettepe University Ethical Committee

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2009

Primary Completion (Actual)

September 1, 2010

Study Completion (Actual)

September 1, 2010

Study Registration Dates

First Submitted

December 12, 2013

First Submitted That Met QC Criteria

February 25, 2014

First Posted (Estimate)

February 27, 2014

Study Record Updates

Last Update Posted (Estimate)

February 27, 2014

Last Update Submitted That Met QC Criteria

February 25, 2014

Last Verified

February 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spasticity

Clinical Trials on Kinesiotape plus thenar pressure (PPTG)

3
Subscribe